{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:28:10Z","timestamp":1794652090368,"version":"4.9.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>Acquired cystic disease of kidney\u2013associated renal cell carcinoma (ACD-RCC) is a distinct subtype of renal cell carcinoma with unique morphologic and clinicopathologic features. Generally, ACD-RCC is regarded as an indolent tumor; however, prognostic and outcomes data have been conflicted by the limited and relatively low number of cases with patient follow-up or adverse events. In this study, we focused on the histology of metastatic lesions and identifying prognostic factors associated with metastatic progression. From 32 cases in the cohort, 9 patients had metastasis [ACD-RCC (M+)] and 23 patients were without metastasis [ACD-RCC (M\u2212)]. The median age of patients was 52 years; right side, n=10; left side, n=18; bilateral, n=4; median tumor size=2.6\u2009cm; median hemodialysis duration=17\u2009y; and the median duration of follow-up was 50\u2009mo. Immunohistochemistry showed ACD-RCC to be racemase positive and CK7 negative to focally positive within tumor cells, with consistent positivity for renal histogenesis-associated markers (PAX8 and RCC antigen); S100A1 was a less reliable marker at metastatic sites. All metastatic ACD-RCC except 2 cases involved lymph nodes (para-aortic, renal hilar, subclavicular). Overall, 6\/9 (67%) had visceral metastasis to sites including lung (n=3), liver (n=3), bone (n=5), stomach (n=1), and brain (n=1). In total, 5\/9 (56%) metastatic tumors had distinctive cystic growth pattern at the metastatic site; intriguingly metastatic tumors had intrametastatic oxalate crystal deposition, a pathognomonic feature associated with primary tumors. Four of nine (44%) patients with ACD-RCC (M+) had fatal outcomes due to metastatic disease. Clinically significant adverse prognostic features associated with metastasis [median follow-up 47\u2009mo, ACD-RCC (M+) vs. ACD-RCC (M\u2212), 50\u2009mo] included: duration of hemodialysis (\u226520 vs. &lt;20\u2009y, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0085) and tumor necrosis (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.049). Because of sufficient overlap between these parameters, the study was not able to identify parameters that would be reliable in further management strategies, in clinical settings. Our data indicate that ACD-RCC is a tumor which has distinct metastatic potential with nodal and visceral tropism and proclivity for cystic morphology at metastatic sites; this is the first report of the presence of oxalate crystals in metastatic tumors. Our data suggest that ACD-RCC patients with prolonged hemodialysis and tumoral coagulative necrosis require additional surveillance in view of the association of these parameters with metastatic progression.<\/jats:p>","DOI":"10.1097\/pas.0000000000001482","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T06:26:56Z","timestamp":1586413616000},"page":"1031-1039","source":"Crossref","is-referenced-by-count":24,"title":["Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease\u2013associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions"],"prefix":"10.1097","volume":"44","author":[{"given":"Fumiyoshi","family":"Kojima","sequence":"first","affiliation":[{"name":"Human Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin S.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibu","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Human Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Iba","sequence":"additional","affiliation":[{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Collier","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Clinical Study Support Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Division of Central Laboratory Medicine and Pathology, Wakayama Medical University, Wakayama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Warigaya","sequence":"additional","affiliation":[{"name":"Human Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Human Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kochi Red-cross Hospital, Kochi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Murata","sequence":"additional","affiliation":[{"name":"Human Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/pin.12718","article-title":"Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study","volume":"68","author":"Kondo","year":"2018","journal-title":"Pathol Int"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.pas.0000152131.58492.97","article-title":"Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study","volume":"29","author":"Sule","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5114\/pjp.2017.73926","article-title":"Acquired cystic disease-associated renal cell carcinoma: a clinicopathological study of seven cases","volume":"68","author":"Kuroda","year":"2017","journal-title":"Pol J Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00795-013-0028-x","article-title":"Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features","volume":"46","author":"Ahn","year":"2013","journal-title":"Med Mol Morphol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/dc.20816","article-title":"Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases","volume":"36","author":"Rivera","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2559.2010.03480.x","article-title":"Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis","volume":"56","author":"Enoki","year":"2010","journal-title":"Histopathology"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1066896911414273","article-title":"Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma","volume":"20","author":"Bhatnagar","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison","volume":"136","author":"Ozcan","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R14-20230922","first-page":"349","article-title":"A case of ACD-associated RCC with lymph node metastasis and contralateral renal carcinoma after nephrectomy","volume":"62","author":"Makino","year":"2016","journal-title":"Hinyokika Kiyo"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2019.09.011","article-title":"Pathologic characterization of renal epithelial neoplasms arising in non-functioning kidneys","volume":"97","author":"Lin","year":"2019","journal-title":"Hum Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1464-410X.2009.08817.x","article-title":"Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis","volume":"105","author":"Nouh","year":"2010","journal-title":"BJU Int"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/ndt\/gfq529","article-title":"Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis?","volume":"26","author":"Sassa","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.2009.03361.x","article-title":"Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma","volume":"55","author":"Pan","year":"2009","journal-title":"Histopathology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/pin.12232","article-title":"Acquired cystic disease-associated renal cell carcinoma with a focal sarcomatoid component: report of a case showing more pronounced polysomy of chromosomes 3 and 16 in the sarcomatoid component","volume":"65","author":"Tajima","year":"2015","journal-title":"Pathol Int"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00795-010-0496-1","article-title":"Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study","volume":"44","author":"Kuroda","year":"2011","journal-title":"Med Mol Morphol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/dc.21751","article-title":"Imprint cytological findings of acquired cystic disease-associated renal-cell carcinoma: a close relationship to papillary renal-cell carcinoma","volume":"40","author":"Yamaguchi","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/modpathol.3800604","article-title":"Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study","volume":"19","author":"Cossu-Rocca","year":"2006","journal-title":"Mod Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum","volume":"31","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R24-20230922","first-page":"260","article-title":"Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases","volume":"122","author":"Dry","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"R25-20230922","first-page":"1367","article-title":"Calcium oxalate crystals in breast biopsies. An overlooked form of microcalcification associated with benign breast disease","volume":"113","author":"Radi","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/PAS.0000000000000204","article-title":"Utility of birefringent crystal identification by polarized light microscopy in distinguishing thyroid from parathyroid tissue on intraoperative frozen sections","volume":"38","author":"Wong","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11926-013-0340-4","article-title":"Update on oxalate crystal disease","volume":"15","author":"Lorenz","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00000478-199307000-00007","article-title":"Birefringent (calcium oxalate) crystals in thyroid diseases. A clinicopathological study with possible implications for differential diagnosis","volume":"17","author":"Katoh","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"669","DOI":"10.33549\/physiolres.932712","article-title":"S100A1: a major player in cardiovascular performance","volume":"63","author":"Duarte-Costa","year":"2014","journal-title":"Physiol Res"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/modpathol.3800828","article-title":"Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study","volume":"20","author":"Rocca","year":"2007","journal-title":"Mod Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2559.2007.02655.x","article-title":"S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma","volume":"50","author":"Li","year":"2007","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:03:33Z","timestamp":1695423813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001482","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}